Prelude Capital Management, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $183,134 - $340,724	-10,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $112,579 - $242,565	10,300 New	10,300 $228,000
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $14,234 - $17,655	-1,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $3,957 - $4,998	300 Added 37.5%	1,100 $16,000
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $11,296 - $14,663	800 New	800 $13,000
Q1 2020 May 15, 2020	SELL	$11.34 - $21.46 $13,608 - $25,752	-1,200 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $4,656 - $25,704	1,200 New	1,200 $24,000

191

56.2M

499K

637K

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.02B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.